Physician profile
John D Kasper
NPI 1649257320
$5,789.85
in general payments reported to CMS, 2019-2025
33 companies · $699 in 2025
The $699 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $23.62 · 2021: $1,693 · 2022: $1,658 · 2023: $595 · 2024: $912 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,189 · Education: $16.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,188.60 |
| Education | $16.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,667.93 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $662.51 | 2021-2025 | |
| Stryker Corporation | $620.23 | 2021 | |
| Scilex Pharmaceuticals INC. | $570.33 | 2022-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $551.61 | 2021-2025 | Xtampza |
| Abbott Laboratories | $241.77 | 2021-2025 | Proclaim |
| Hikma Pharmaceuticals USA | $166.31 | 2021-2022 | |
| Foundation Fusion Solutions, LLC | $156.82 | 2022 | |
| Abbvie INC. | $145.65 | 2023-2024 | |
| Braeburn INC. | $113.25 | 2023-2025 | Brixadi |
| Indivior INC. | $85.97 | 2024-2025 | Sublocade |
| Curonix LLC | $82.80 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $82.70 | 2021 | |
| Amgen INC. | $64.84 | 2021-2022 | |
| Intuitive Surgical, INC. | $64.14 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $48.76 | 2021 | |
| Bard Peripheral Vascular, INC. | $47.70 | 2019 | |
| Globus Medical, INC. | $45.87 | 2025 | Senza, Omnia |
| Spinal Simplicity, LLC | $45.36 | 2024-2025 | Ha Minuteman G3-R |
| Orexo US, INC. | $41.36 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.97 | 2021-2025 | Relistor |
| Ethicon US, LLC | $35.39 | 2019-2020 | |
| Medtronic, INC. | $34.41 | 2021-2022 | |
| Tei Biosciences INC | $25.82 | 2019 | |
| Allergan, INC. | $24.86 | 2022 | |
| Redhill Biopharma INC. | $20.00 | 2021 | |
| Angiodynamics, INC. | $19.05 | 2019 | |
| Integra Lifesciences Corporation | $16.75 | 2019 | |
| Saluda Medical Americas, INC. | $16.61 | 2025 | Evoke |
| Baudax Bio INC. | $15.25 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.95 | 2019 | |
| Azurity Pharmaceuticals, INC. | $12.86 | 2023 | Horizant |
| Medtronic Vascular, INC. | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.